Volume | 40,645 |
|
|||||
News | - | ||||||
Day High | 0.7667 | Low High |
|||||
Day Low | 0.711 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
YS Biopharma Company Ltd | YS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.72 | 0.711 | 0.7667 | 0.75 | 0.704 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
97 | 40,645 | $ 0.7415325 | $ 30,140 | - | 0.3503 - 1.94 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:12:08 | 13 | $ 0.74 | USD |
YS Biopharma Company Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.44M | 93.06M | - | 687.2M | -283.47M | -3.05 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
YS Biopharma News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.8229 | 0.85 | 0.704 | 0.7712075 | 52,850 | -0.0729 | -8.86% |
1 Month | 0.75 | 1.0285 | 0.70 | 0.8468399 | 167,639 | 0.00 | 0.00% |
3 Months | 0.40 | 1.0285 | 0.3607 | 0.6360156 | 193,281 | 0.35 | 87.50% |
6 Months | 0.476 | 1.0285 | 0.3503 | 0.5674316 | 161,284 | 0.274 | 57.56% |
1 Year | 1.89 | 1.94 | 0.3503 | 1.19 | 494,865 | -1.14 | -60.32% |
3 Years | 12.67 | 12.93 | 0.3503 | 1.39 | 577,552 | -11.92 | -94.08% |
5 Years | 12.67 | 12.93 | 0.3503 | 1.39 | 577,552 | -11.92 | -94.08% |
YS Biopharma Description
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China. |